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FTCAbstract Background: Aortic corrected flow time (FTc) is easily measured by Doppler techniques.
Recent data using transesophageal Doppler suggest that it may predict fluid responsiveness in
critical care. This use of FTc has not previously been evaluated in septic shock, and only one
preliminary study has incorporated transcutaneously measured FTc, denoting its importance in
prediction of fluid responsiveness in septic patient. Furthermore, no comparison has been made
between transesophageal FTc and central venous pressure (CVP).
Objective: The aim of our study was to compare the impact of using FTc versus CVP as a guide for fluid
resuscitation in septic shock on stroke volume denoting cardiac responsiveness for fluid administration.
Methods: This was a prospective study of 46 consecutive adult septic shock patients (in sinus
rhythm). 44 patients were mechanically ventilated, treated with intravenous fluid challenge
(500 mL over 15 min), guided with CVP in control group and guided by FTC in Doppler group
assessment incorporating transesophageal aortic Doppler (CardioQ) measurements in a surgical
tertiary intensive care unit. Stroke volume (SV), mechanical ventilation days, length of stay and
mortality of both groups were recorded.
Results: Fourty one patients demonstrated an increase in stroke volume (SV) by more than 10%
(fluid responders) while five patients were non responders. There were statistically significant
increases in SV after 1 h post resuscitation in the Doppler group as the values were 63.87 ± 25.87
& 81.39 ± 35.02 in the control group and the Doppler group respectively (p value = 0.034). There
were statistically significant differences in FTc values after 1 h [397.00 (390.00–404.00) & 362.00
(351.00–377.00)] between non-responders and responders respectively (p value was 0.003) and after
6 h [377.00 (376.00–378.00) & 330.00 (314.00–353.00)] between non-responders and responders
respectively (p value was 0.007).
Conclusion: Transesophageal aortic Doppler is a simple, non-invasive tool of guiding fluid therapy
in patients with severe sepsis and septic shock. FTC change was a better predictor of fluid respon-
siveness than CVP in septic shock. There was higher significant difference in SV after resuscitation
when using FTC as guidance.
 2016 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.
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Septic shock is an extremely complex disorder whose deranged
hemodynamics results from the interplay of hypovolemia,
vasodilatation, peripheral blood pooling, and extravasation
of fluid into the interstitial space.
Intravenous fluids remain the cornerstone of treating
patients with septic shock. The goal of fluid resuscitation in
severe sepsis and septic shock is not merely achieving a prede-
termined value, but rather optimizing systemic oxygen delivery
(cardiac preload, afterload, arterial oxygen content, contractil-
ity or stroke volume) [1].
Many factors may contribute to these findings, including
physiologic compensatory mechanisms. These mechanisms
often mask the true nature of blood flow. For example,
whereas a patient may have a significant decrease in cardiac
output (CO), the initial compensatory response of reflex vaso-
constriction results in increased systemic vascular resistance
and a normal blood pressure. The compensatory effects inhibit
the clinician’s ability to assess decreased blood flow and oxy-
gen delivery accurately [2–4].
Surprisingly, dosing intravenous fluid during resuscitation
of shock remains largely empirical. Too little fluid may result
in tissue hypoperfusion and worsen organ dysfunction; how-
ever, over-prescription of fluid also appears to impede oxygen
delivery and compromise patient outcome. Several studies
demonstrated that positive fluid balance was associated with
increased mortality and the duration of mechanical ventilation
[5,6].
In a randomized controlled, single-center study, early quan-
titative resuscitation improved survival for emergency depart-
ment patients presented with septic shock [7].
The 2012 Surviving Sepsis Guidelines suggest the infusion
of intravenous fluids until achieving a central venous pressure
of 8–12 mmHg and raise this target to 12–15 mmHg in patients
with mechanical ventilation [8].
However, there are no recommendations as to when it is
appropriate to discontinue or to reduce the rate of administra-
tion of intravenous fluid.
The measurement of descending aortic blood flow via an
esophageal ultrasound probe offers an alternative method of
monitoring circulatory status. Measured parameters include
peak velocity (PV) and systolic flow time [FTc, corrected for
heart rate (HR)]. PV (cm s1) is an index of left ventricular
contractility while FTc reflects ventricular preload. Concurrent
changes in PV and FTc reflect changes in afterload. The tech-
nique has been validated extensively compared with pul-
monary artery catheters and is now widely used in adult
anesthesia and intensive care units practice [8,9].
To the best of our knowledge there is only one published
small study on the use of transcutaneous FTc in patients with
septic shock [9].
Optimal fluid loading after cardiac surgery or early in the
course of septic shock also may ameliorate morbidity and mor-
tality [10].
Taken together, fluid therapy should aim at physiologically
and clinically relevant endpoints, in order to improve outcome,
but further refinement of these endpoints seems warranted [1].
We tried to compare the impact of using FTc versus CVP as
a guide for fluid resuscitation in septic shock on stroke volume
denoting cardiac responsiveness for fluid administration.2. Patients and methods
This study was conducted in the surgical intensive care unit
(SICU), at the faculty of medicine, Cairo University (Egypt),
from November 2012 to February 2014.
Out of 350 patients admitted to the surgical intensive care
unit (SICU), 46 septic patients met the inclusion criteria and
were enrolled in the study.
The study was done after approval by local ethics commit-
tee and after obtaining written informed consent from the
patients’ next of kin.
2.1. Study population
2.1.1. Inclusion criteria
1. Ventilated patients who met the criteria of septic shock [8].
2. Mean arterial pressure 660 mmHg after at least a 1000 mL
crystalloid bolus.2.1.2. Exclusion criteria
1. Age less than 18 years.
2. Cardiac rhythm other than sinus.
3. Moderate to severe valvular heart disease.
4. Pregnant patients.
5. Patients who were on hemodialysis.
6. Relative contraindications to the use of the esophageal
Doppler probe, such as orofacial and esophageal injury
or other known oropharyngeal and esophageal disease.
7. Late stages of sepsis i.e. hypotension persisted >12 h or
received previous fluid resuscitation.2.1.3. Randomization
Patients who met the inclusion criteria were randomly assigned
to the protocol group (Doppler) or the control group using
computer generated number. Randomization was concealed
using sequentially numbered, sealed opaque envelope tech-
nique. There were no restrictions or stratification in the ran-
domization process. The allocation envelope was opened by
the attending resident at the time of ICU admission. Data were
analyzed on an intention-to-treat basis and included all
patients who were randomly assigned.
2.2. Study protocol
2.2.1. Control group
The patients received 500 mL of normal saline every 15 min till
the CVP reached 12–15 mmHg with maximum administration
of 60 mL/kg.
2.2.2. Doppler group
The patient received 500 mL of normal saline every 15 min till
the FTc P350 ms with maximum administration of 60 mL/kg
2.2.3. In both groups
If the mean arterial pressure is less than 65 mmHg, nore-
pinephrine was given in a dose of 0.1–0.7 lg/kg/min to main-
tain a mean arterial pressure of at least 65 mmHg. If the
Assessed for eligibility
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Figure 1 CONSORT diagram showing the flow of participants through each stage.
Transesophageal Doppler corrected systolic flow time versus central venous pressure 183central venous oxygen saturation (ScVO2) is less than 70%,
red blood cells were transfused to achieve a hematocrit of at
least 30%. After the central venous pressure, mean arterial
pressure, and hematocrit were optimized, if ScVO2 <70%,
dobutamine administration was started at a dose of 2.5 lg/
kg/min., a dose that was increased by 2.5 lg per kilogram
per minute every 30 min until the central venous oxygen satu-
ration is 70 percent or higher or until a maximal dose of 20 lg/
kg/min. was given.2.2.4. Transesophageal Doppler
The transesophageal Doppler was inserted by intensivist who
had inserted at least 5 transesophageal Doppler’s each prior
to the study.
A 5-MHz, continuous-wave ED transducer (Deltex TM)
connected to a spectral analyser (CardioQ, Deltex Medical,
Chichester, UK) was inserted and orientated. Following oral
introduction, the probe was advanced gently until its tip was
located in the mid-esophagus and then manipulated until the
Table 1 Demographics data presented as mean, standard deviation and frequency.
Characteristics Control group (N= 23) Doppler group (N= 23) PV
Age (years) 50.13 ± 16.81 45.52 ± 14.04 0.275
Male sex – no. (%) 14 (60.9%) 13 (56.5%) 0.765
APACHE II score 27.22 ± 7.48 22.87 ± 5.93 0.039
SOFA day 2 8.70 ± 3.52 6.87 ± 2.16 0.050
SOFA day 3 9.00 ± 3.83 7.13 ± 2.63 0.125
Total LOS (days) 6.70 ± 4.49 15.61 ± 25.10 0.273
Mortality outcome 19 (82.6%) 16 (69.6%) 0.300
Plus–minus values are means ± standard deviation. There were significant differences in baseline characteristics across groups, PV (p value)
<0.05 is considered statistically significant. APACHE II (Acute Physiology and Chronic Health Evaluation). SOFA (Sequential Organ Failure
Assessment), MV (mechanical ventilation), LOS (length of stay).
Table 2 Fluid resuscitation volumes, data are presented as mean and standard deviation.
Type of fluid Control group Doppler group p value
Crystalloid (mL)
T1 2021.74 ± 1030.54 2391.30 ± 664.98 0.051
T12 2955.00 ± 1109.30* 3619.57 ± 719.02 0.001
Colloids (mL)
T1 250.00 ± 370.01 431.82 ± 495.11 0.203
T12 282.61 ± 363.88 478.26 ± 488.00 0.168
Blood units 3.33 ± 1.78* 1.92±.86 0.015
FFP units 4.00±.00 2.67 ± 1.15 0.182
Total fluid T1 2913.04 ± 871.29* 2336.96 ± 685.10 0.013
Total fluid in T12 4412.39 ± 1486.57 3652.17 ± 906.10 0.054
p value <0.05 considered statistically significant. T0 (measurement on enrollment), T1 (measurement after 1 h post resuscitation), T12
(measurement after 12 h post resuscitation), FFP (fresh frozen plasma).
* Denotes statistical significant difference relative to the other group.
Table 3 Responder’s main parameters.
Non-responder Responder p-value
Median; (IQR) Median; (IQR)
CVP
T0 5.00 (3.00–5.00) 6.00 (3.00–7.00) 0.294
T1 13.00 (12.00–14.00) 14.00 (12.00–16.00) 0.568
T6 11.00 (11.00–13.00) 8.00 (6.00–12.00) 0.145
T12 10.00 (8.00–12.00) 8.00 (5.00–10.00) 0.288
FTC
T0 380.00 (344.00–384.00)a 293.00 (271.00–319.00) 0.000
T1 397.00 (390.00–404.00)a 362.00 (351.00–377.00) 0.003
T6 377.00 (376.00–378.00)a 330.00 (314.00–353.00) 0.007
T12 325.00 (313.00–351.00) 315.00 (300.00–332.00) 0.158
Total fluid T1 3000.00 (3000.00–3500.00)a 2500.00 (2000.00–3000.00) 0.049
Total fluid in T12 4100.00 (4080.00–4200.00) 3700.00 (3100.00–4700.00) 0.298
Data presented with median and inter quartile range (IQR), p value <0.05 considered statistically significant. T0 = measurement on enroll-
ment, T1 measurement after 1 h post resuscitation, T6 measurement after 6 h post resuscitation, T12 = measurement after 12 h post
resuscitation.
a Data are presented as median and range.
184 W. Hamimy et al.transducer obtained the characteristic blood flow signal.
Gain setting was adjusted to obtain the best outline of the
aortic velocity waveform within 30 s. The average of 5
consecutive readings was taken. Prior to each measurement,probe position was verified to ensure optimal acquisition
of the maximal velocity signal. Both cardiac output
and flow time constant (FTc) were measured for each
patient.
Figure 2 Mean arterial blood pressure pre- and post resuscita-
tion in both groups. T0 = measurement on enrollment, T1
measurement after 1 h post resuscitation, T6 measurement after
6 h post resuscitation, T12 = measurement after 12 h post
resuscitation.
Figure 3 CVP pre- and post resuscitation in both groups.
CVP = central venous pressure, T0 = measurement on enroll-
ment, T1 measurement after 1 h post resuscitation, T6 measure-
ment after 6 h post resuscitation, T12 = measurement after 12 h
post resuscitation.
Figure 4 FTC pre- and post resuscitation in both groups.
T0 = measurement on enrollment, T1 measurement after 1 h post
resuscitation, T6 measurement after 6 h post resuscitation,
T12 = measurement after 12 h post resuscitation.
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2.3.1. Hemodynamic variables
In both groups, CVP, SV, FTc, hemodynamic data were
recorded at baseline before volume replacement and at 1, 6,
and 12 h after protocol initiation.
2.3.2. Other variables
Acute Physiology and Chronic Health Evaluation II
(APACHE II) score had been calculated after admission to
the ICU. Sequential Organ Failure Assessment (SOFA) score
was measured at 0, 24, 48 h after ICU admission.
According to the degree of fluid responsiveness, patients
were divided into 2 groups:1. Responders were defined as patients who had an increase in
SV P10% of baseline measurements by trans-esophageal
Doppler.
2. Non-responders were defined as patients who had an
increase in SV <10% of baseline measurements by trans-
esophageal Doppler.
2.4. Statistical analysis
Data were coded and entered using the statistical package
SPSS version 21. Data were summarized using mean, standard
deviation, median, minimum and maximum. Comparisons
between variables over time were done using repeated measure
analysis of variance (ANOVA) with multiple comparisons post
hoc test in normally distributed quantitative variables while
non-parametrical Friedman test and Wilcoxon test were used
for non-normally distributed variables. Correlation was done
to test for linear relations between quantitative variables by
spearman correlation coefficient. p-values less than 0.05 were
considered as statistically significant.
3. Results
From January 2012 through February 2014, we enrolled 70
patients. Twenty-four patients were excluded from the study
[(5 patients) Known to be on dialysis, (9 patients) showing
arrhythmias, (7 patients) arrested few hours post resuscitation
trial, (2 patients) well known and documented to have valvular
heart disease and one patient had severe orofacial trauma with
multiple surgeries which militate against Doppler probe inser-
tion)] leaving a final cohort of 46 patients for the analysis: 23 in
the control group and 23 in Doppler group (see Fig. 1).
Patient characteristics and demographic data are presented
in Table 1. There were no statistically significant differences
between the two groups at baseline, except for lower APACHE
II score in the Doppler group than in the control group with p
value 0.039 (see Table 2).
Figure 5 ScVO2 pre- and post resuscitation in both groups.
ScVO2 = central venous oxygen saturation
* significant p value
between control and Doppler groups. p value <0.05. T0 = mea-
surement on enrollment, T1 measurement after 1 h post resusci-
tation, T6 measurement after 6 h post resuscitation,
T12 = measurement after 12 h post resuscitation.
Figure 6 SV pre- and post resuscitation in both groups. SV
(stroke volume), * (significant p value between control and
Doppler groups, p-value <0.05), T0 = measurement on enroll-
ment, T1 measurement after 1 h post resuscitation, T6 measure-
ment after 6 h post resuscitation, T12 = measurement after 12 h
post resuscitation.
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ders was 41 patients (89.01%) and 5 patients (10.09%) were
non-responders; there were statistically significant differences
regarding FTc on enrollment [380.00 (344.00–384.00) &
293.00 (271.00–319.00)] between non-responders and respon-
ders respectively, p value was (0.000), in FTc after 1 h
[397.00 (390.00–404.00) & 362.00 (351.00–377.00)] between
non-responders and responders respectively, p value was
(0.003) and in FTc after 6 h [377.00 (376.00–378.00) &
330.00 (314.00–353.00)] between non-responders and respon-
ders respectively, and p value was (0.007) (Table 3).
Also, there were statistically significant differences regard-
ing the total fluids administrated after 1 h [3000.00 (3000.00–
3500.00) & 2500.00 (2000.00–3000.00)] between non-
responders and responders respectively, and p value was
0.049 (Table 3).
There were no statistically significant differences at baseline
and after 1, 6 and 12 h post resuscitation regarding mean ABP,
FTC and CVP between the two groups as shown in Figs. 2–4.
Baseline ScVO2 was higher in control group than
in Doppler group (72.3 ± 7.43, 62.1 ± 9.71) respectively
p=<0.001, however one hour after fluid challenge ScVO2
significantly increased in Doppler group more than in control
group (70.48 ± 5.24, 66.35 ± 7.34) with p value of 0.043
(Fig. 5).
Regarding stroke volume (SV), there was only statistically
significant increase in SV after 1 h post resuscitation in the
Doppler group as the values were 63.87 ± 25.87 & 81.39
± 35.02 in control group and Doppler group respectively
(p value = 0.034) (Fig. 6).
4. Discussion
Using trans-esophageal aortic Doppler is a simple, non-
invasive tool of guiding fluid therapy in patients with severe
sepsis and septic shock. FT changes were a better predictor
of change in Doppler derived stroke volume following fluid
challenge (fluid responsiveness) than CVP.In the current study, 41 patients demonstrated an increase
in stroke volume P10% (responders) while 5 patients were
non-responders To initial fluid resuscitation, the best cut-off
value of FTc was 332 m sec, below this value patients were
considered responders and above this value they were non-
responders.
These results were in line with Sturgess et al. [9] who com-
pared FTc, BNP and central venous pressure as predictors of
fluid responsiveness in septic shock patients without cardiac
dysrhythmia in a prospective study of 10 consecutive adult sep-
tic shock patients treated with intravenous fluid challenge (4%
albumin 250 mL over 15 min) in a tertiary intensive care unit
and concluded that transcutaneous FTc was a better predictor
of fluid responsiveness than either Brain Natriuretic peptide
(BNP) nor CVP in septic shock.
Lee et al. [11] who evaluated the ability of FTc to predict
fluid responsiveness and compared this with the abilities of
other preload indices, such as pulse pressure variation (PPV),
central venous pressure (CVP), and left ventricular end-
diastolic area index (LVEDAI), demonstrated that FTc and
PPV before fluid loading differed between responders
(n= 11) and non-responders (n= 9), and correlated with
changes in stroke volume index and concluded that FTc pre-
dicted fluid responsiveness. However, FTc should be used in
conjunction with other clinical information.
On the other hand our results showed that static values of
CVP did not predict hemodynamic response to fluid challenge,
as the magnitude of the change in SV was (<10%) which were
in line with Marik et al. [12] who conducted a systematic
review and demonstrated a very poor relationship between
CVP and blood volume as well as the inability of CVP/Del-
taCVP to predict the hemodynamic response to fluid challenge
and recommended that CVP should not be used to make clin-
ical decisions regarding fluid management.
De Waal et al. [13] demonstrated that the correlation coef-
ficient for the relationship between percent of increase in SVI
(stroke volume index) and CVP prior to the volume load
was poor for CVP.
Transesophageal Doppler corrected systolic flow time versus central venous pressure 1875. Limitations
We could not estimate total amount of fluids given to the
patients before admission to ICU.
6. Conclusion
Transesophageal aortic Doppler is a simple, non-invasive tool
of guiding fluid therapy in patients with severe sepsis and sep-
tic shock. FTc change was a better predictor of fluid respon-
siveness than CVP in septic. Regarding SV, there was higher
significant difference in SV after 1 h post resuscitation when
using FTC as a guidance. However further randomized trials
are required to validate these results.
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